Investors were disappointed with Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) recent earnings release. Our analysis found several concerning factors in the earnings report beyond the strong statutory ...
Source LinkInvestors were disappointed with Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) recent earnings release. Our analysis found several concerning factors in the earnings report beyond the strong statutory ...
Source Link
Comments